Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

p53 mutations in human bladder cancer: genotypic versus phenotypic patterns

C Cordon-Cardo1, G Dalbagni, G T Saez

  • 1Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

International Journal of Cancer
|February 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychosocial and environmental motivational key factors behind the parenthood desire in infertile couples at the time of COVID-19.

Journal of assisted reproduction and genetics·2024
Same author

Severe pulmonary hypertension and circulatory failure associated with Congenital syphilis. Case report.

Journal of neonatal-perinatal medicine·2024
Same author

RISEinFAMILY project: the integration of families at neonatal intensive care units (NICUs) to empower them as primary caregivers: study protocol for a stepped wedge cluster controlled trial.

Trials·2024
Same author

Correction to: The HERA (Hyper‑response Risk Assessment) Delphi consensus for the management of hyper‑responders in in vitro fertilization.

Journal of assisted reproduction and genetics·2023
Same author

The HERA (Hyper-response Risk Assessment) Delphi consensus for the management of hyper-responders in in vitro fertilization.

Journal of assisted reproduction and genetics·2023
Same author

Mosaic results after preimplantation genetic testing for aneuploidy may be accompanied by changes in global gene expression.

Frontiers in molecular biosciences·2023

Immunohistochemistry (IHC) accurately detects p53 mutations in bladder cancer, correlating well with genetic analysis. This method offers a sensitive and specific approach for clinical material.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • p53 gene mutations are crucial in bladder cancer development.
  • Variations in detection methodologies can lead to discrepancies in identifying p53 alterations.
  • Accurate assessment requires correlating molecular and morphological data.

Purpose of the Study:

  • To characterize p53 mutation patterns in bladder cancer.
  • To evaluate the sensitivity and specificity of various assays for detecting p53 mutations.
  • To correlate genotypic and phenotypic characteristics using a novel experimental design.

Main Methods:

  • Analysis of paired normal and tumor tissues from 42 bladder cancer patients.
  • Utilized immunohistochemistry (IHC), restriction-fragment-length polymorphism, single-strand-conformation polymorphism (SSCP), and sequencing.

Related Experiment Videos

  • Integrated molecular genetics and immunopathology techniques with morphological evaluation.

    • Main Results:

    • Nuclear p53 over-expression observed in 26/42 tumors.
    • Mutations detected in 14/42 cases via SSCP and sequencing, with one tumor showing 3 mutations.
    • Strong association found between p53 over-expression, 17p LOH, and mutation detection by SSCP/sequencing.

    Conclusions:

    • Immunohistochemistry (IHC) demonstrated high accuracy (90.3%) for detecting p53 mutations in bladder cancer.
    • IHC is a highly sensitive and specific method for clinical material when used appropriately.
    • The study highlights the importance of integrated methodologies for reliable genetic alteration analysis.